Clinical Trials
67 trialsSingle-Patient Expanded Access Protocol - RNA-LP in a Patient With Recurrent Osteosarcoma
University of Florida
EMTP
Phoenix Children's Hospital
Fecal Microbiota Transplant for Neuroblastoma in a Single Patient
ProgenaBiome
EAP
Roswell Park Cancer Institute
131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults
Memorial Sloan Kettering Cancer Center
Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)
The University of Texas Health Science Center at San Antonio
Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.
Case Comprehensive Cancer Center
Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL
University of Texas Southwestern Medical Center
An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)
Lynkcell Europe
131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma
University of Texas Southwestern Medical Center
TRIANGLE
Petrov, Andrey
Expanded Access Neoantigen Vaccine in Solid Tumors
Washington University School of Medicine
Compassionate Use of BYL 719 Alpelisib
New Mexico Cancer Research Alliance
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer
University of Texas Southwestern Medical Center
Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma
Children's Hospital Medical Center, Cincinnati
Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer
University of Michigan
Firefly
Tulane University
18F-FDOPA PET in Neuroendocrine Tumours
British Columbia Cancer Agency
Therasphere for Unresectable Primary or Secondary Liver Neoplasia
H. Lee Moffitt Cancer Center and Research Institute
Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation
Emory University
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer
Stanford University
Expanded Access [Ga-68] PSMA-11 PET Imaging
Mayo Clinic
Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch
UNC Lineberger Comprehensive Cancer Center
Compassionate Use Re-Infusion of ATLCAR.CD30
UNC Lineberger Comprehensive Cancer Center
Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma
Fuda Cancer Hospital, Guangzhou
Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer
University of Washington
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
University of California, San Francisco
68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)
Jonsson Comprehensive Cancer Center
C11 Sodium Acetate PET/CT Imaging of PCa
Jonsson Comprehensive Cancer Center
Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography
Memorial Sloan Kettering Cancer Center
3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)
Oregon Health and Science University
Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients
Massachusetts Eye and Ear Infirmary
An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
Center Trials & Treatment
Treatment of Lambert-Eaton Syndrome With 3,4 DAP
University of California, Davis
Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
University of Pittsburgh
Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma
Jonsson Comprehensive Cancer Center
Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
Masonic Cancer Center, University of Minnesota
Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies
University of Colorado, Denver
Compassionate Use: Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With Trametinib
Jonsson Comprehensive Cancer Center
PURSE
Zhejiang University
Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
University of Kansas Medical Center
MLN8237 for a Subject With Adenocarcinoma of the Prostate
The University of Texas Health Science Center at San Antonio
Expanded Access for Pembrolizumab (MK-3475)
Center Trials & Treatment
Treatment With Crizotinib Single Patient Expanded Access IND 134375
University of Pittsburgh
Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma
Dana-Farber Cancer Institute
Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer
Leo W. Jenkins Cancer Center
68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors
Stanford University
Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer
University of Pennsylvania
Single Subject Neratinib in Bladder Cancer (NRR)
UNC Lineberger Comprehensive Cancer Center
Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
City of Hope Medical Center